ONCY
Oncolytics Biotech Inc
0.6745$
+1.7%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +10.3% | -10.1% | -44.1% | +5.1% | +409.1% | -8.1% | +1.3% | -36.1% | +5.2% | -71.4% | -19.5% | |
| – | -56.2% | -5.5% | +42.5% | +144.7% | +3.8% | +74.1% | +49.5% | -54.2% | -11.0% | +27.1% | +56.6% | |
| – | -113.9% | – | +70.5% | +146.1% | +1,200.2% | -101.5% | – | -83.9% | – | – | – | |
| – | – | – | -91.9% | +2,058.8% | -146.0% | – | -532.4% | – | +361.8% | +89.6% | -53.2% | |
| – | -29.1% | -78.3% | +349.5% | +1.6% | -89.9% | +165.9% | +886.2% | -85.8% | -85.1% | +2,785.6% | -96.6% | |
| – | -24.7% | -62.7% | – | -105.4% | -89.9% | +165.9% | +886.2% | +5,156.3% | – | -101.1% | -96.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | -82.9% | +1,947.0% | +207,747.3% | +3.8% | – | – | – | – | – | – | |
| – | – | – | +0.0% | +0.0% | +0.0% | +3.0% | -20.7% | +4.2% | +6.8% | -14.5% | – | |
| – | +161.7% | -96.0% | +1,240.1% | +3.8% | +58.0% | +89.3% | -17.0% | -72.8% | +168.2% | -79.2% | +180.8% | |
| – | – | -221.5% | – | – | -76.0% | +3,709.5% | -41.2% | -317.2% | – | -187.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.